Hitoshi Minamiguchi
Overview
Explore the profile of Hitoshi Minamiguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanda T, Minamiguchi H, Iwami R, Iida O, Higuchi Y
J Arrhythm
. 2025 Mar;
41(2):e70030.
PMID: 40046264
High-resolution mapping with Ripple and LAM modules enabled precise identification of slow pathway ablation targets in a PLSVC patient. This novel approach overcame anatomical challenges, offering a more effective strategy...
2.
Sunaga A, Tanaka N, Egami Y, Minamiguchi H, Oka T, Kawasaki M, et al.
J Arrhythm
. 2025 Jan;
41(1):e13194.
PMID: 39817007
Background: Continuous anticoagulation based on the CHA2DS2-VASc score is recommended to prevent embolism caused by atrial fibrillation (AF), but it does not consider AF episodes. The Apple Watch's continuous heart...
3.
Matsunaga-Lee Y, Inoue K, Tanaka N, Masuda M, Watanabe T, Minamiguchi H, et al.
Heart Rhythm
. 2024 Dec;
PMID: 39701441
No abstract available.
4.
Kanda T, Minamiguchi H, Sakio T, Iwami R, Iida O, Higuchi Y
HeartRhythm Case Rep
. 2024 Dec;
10(11):775-779.
PMID: 39664659
No abstract available.
5.
Yamada C, Ono T, Ino K, Nemoto N, Shinba T, Furumaki H, et al.
Transfusion
. 2024 Sep;
64(10):1980-1992.
PMID: 39288000
Background: Despite several reports on red blood cell (RBC) alloimmunization, the actual prevalence and factors contributing to RBC alloimmunization in transfused patients remain poorly investigated. We examined the association between...
6.
Matsuoka Y, Sotomi Y, Hikoso S, Sunaga A, Nakatani D, Okada K, et al.
J Cardiol
. 2024 Sep;
PMID: 39251131
Background: In patients with persistent atrial fibrillation (AF), extensive ablation for substrate modification, such as linear ablation or complex fractionated atrial electrogram ablation in addition to pulmonary vein isolation (PVI)...
7.
Sunaga A, Matsuoka Y, Nakatani D, Okada K, Kida H, Sakamoto D, et al.
Int J Cardiol
. 2024 Jun;
410:132231.
PMID: 38838745
Background: Extensive ablation in addition to pulmonary vein isolation (PVI) in patients with persistent atrial fibrillation (AF) has not yielded consistent results, indicating diversity in their efficacy. Mitral regurgitation (MR)...
8.
Matsunaga-Lee Y, Inoue K, Tanaka N, Masuda M, Watanabe T, Makino N, et al.
Circ J
. 2024 May;
88(7):1068-1077.
PMID: 38811199
Background: It has not been fully elucidated which patients with persistent atrial fibrillation (PerAF) should undergo substrate ablation plus pulmonary vein isolation (PVI). This study aimed to identify PerAF patients...
9.
Okada M, Inoue K, Tanaka N, Tanaka K, Hirao Y, Iwakura K, et al.
Europace
. 2024 May;
26(5).
PMID: 38691672
Aims: Blood stasis is crucial in developing left atrial (LA) thrombi. LA appendage peak flow velocity (LAAFV) is a quantitative parameter for estimating thromboembolic risk. However, its impact on LA...
10.
Sasaki S, Shibuya Y, Minamiguchi H, Sakio T, Hamanaka Y, Kanda T, et al.
Clin Case Rep
. 2024 Feb;
12(2):e8463.
PMID: 38314190
Key Clinical Message: Left atrial posterior wall on the vertebra is often difficult to obtain stable tissue contact with ablation-catheter. Laser balloon ablation is effective because the compression from the...